FHB
PTCT icon

First Hawaiian Bank’s PTC Therapeutics PTCT Stock Holding History

First Hawaiian Bank’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-29
Closed -$1K – 1339
2019
Q1 		$1K Hold
29
– – ﹤0.01% 1680
2018
Q4 		$1K Hold
29
– – ﹤0.01% 1779
2018
Q3 		$1K Buy
+29
New +$1.2K ﹤0.01% 1808

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

First Hawaiian Bank's PTCT Position: Q2 2019 in Review

First Hawaiian Bank sold out of PTC Therapeutics (PTCT) in Q2 2019, closing a stake of 29 shares — an estimated $1K sold.

First Hawaiian Bank first reported a position in PTCT in Q3 2018 and held it in 3 quarters. The position peaked at $1K in Q1 2019. 176 funds tracked by Wall St. Rank hold PTCT as of Q2 2019.

  • First Hawaiian Bank reported no remaining PTC Therapeutics position as of Q2 2019 after selling out during the quarter.
  • First Hawaiian Bank sold 29 PTC Therapeutics shares in Q2 2019, an estimated $1K.
  • First Hawaiian Bank first reported a position in PTC Therapeutics in Q3 2018 and held it in 3 quarters.
  • First Hawaiian Bank's PTC Therapeutics position peaked at $1K in Q1 2019.
  • 176 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.